|
What is the issue?
21 CFR Part 11 became
law on 20 August 1997. The regulation outlines its criteria for acceptance
of electronic records, electronic signatures, and handwritten signatures. It
allows electronic records to be considered equivalent to paper records and
handwritten signatures. The rule applies to all industry segments regulated
by FDA and includes cGMP, GLP and GCP.
|
|
How will it affect
you?
21 CFR Part 11 has
important implications for any company using a computer for cGMP, GLP and
GCP. The FDA expects affected companies to either be in compliance with Part
11 or to be executing a well-established plan within the company towards
becoming fully compliant. You and your company have the responsibility to
develop strategies to identify, re-mediate and validate non-compliant
systems, as well as creating standards for new systems.
|